Migraine
RecruitingStudy of Eptinezumab Given Intravenously for Prevention of Chronic Migraine in Adolescents Aged 12-17 Years
- Disease:Migraine
- Substances:Eptinezumab
Portugal- Participants:0–17 years
- Substances:Eptinezumab
- Sponsor:H. Lundbeck A/S
Rare diseases
Investigational molecules
Locations
Back to Portugal258 clinical trials in Coimbra, Portugal across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)
Portugal
Portugal
Portugal
Portugal
Portugal
Portugal
Portugal
Portugal
Portugal
Portugal
Portugal
PortugalThe busiest research cities in the country
What the registry says about research in the country
Innovative trials investigating treatments for polypoidal choroidal vasculopathy and thyroid eye disease, focusing on improving visual outcomes and reducing eye-related complications.
Advanced therapeutic approaches using intravitreal injections and targeted medications.
Groundbreaking research addressing various skin conditions including hidradenitis suppurativa, pyoderma gangrenosum, and neurodermatitis.
Novel therapeutic approaches targeting specific inflammatory pathways.
Comprehensive studies exploring treatments for cardiovascular disease and pulmonary arterial hypertension, with focus on preventing major adverse cardiac events.
Innovative therapies targeting specific cardiovascular risk factors.
Advanced research in ischemic stroke, epilepsy, and migraine treatments, exploring both acute interventions and preventive therapies.
Cutting-edge therapeutic approaches for neurological disorders.
Studies focusing on breast cancer, non-small cell lung cancer, and leiomyosarcoma, developing targeted therapies for various cancer types.
Innovative approaches in cancer treatment and management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.